Predicting functional effect of human missense mutations using PolyPhen-2
- PMID:23315928
- PMCID: PMC4480630
- DOI: 10.1002/0471142905.hg0720s76
Predicting functional effect of human missense mutations using PolyPhen-2
Abstract
PolyPhen-2 (Polymorphism Phenotyping v2), available as software and via a Web server, predicts the possible impact of amino acid substitutions on the stability and function of human proteins using structural and comparative evolutionary considerations. It performs functional annotation of single-nucleotide polymorphisms (SNPs), maps coding SNPs to gene transcripts, extracts protein sequence annotations and structural attributes, and builds conservation profiles. It then estimates the probability of the missense mutation being damaging based on a combination of all these properties. PolyPhen-2 features include a high-quality multiple protein sequence alignment pipeline and a prediction method employing machine-learning classification. The software also integrates the UCSC Genome Browser's human genome annotations and MultiZ multiple alignments of vertebrate genomes with the human genome. PolyPhen-2 is capable of analyzing large volumes of data produced by next-generation sequencing projects, thanks to built-in support for high-performance computing environments like Grid Engine and Platform LSF.
Figures






Similar articles
- Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations.Flanagan SE, Patch AM, Ellard S.Flanagan SE, et al.Genet Test Mol Biomarkers. 2010 Aug;14(4):533-7. doi: 10.1089/gtmb.2010.0036.Genet Test Mol Biomarkers. 2010.PMID:20642364
- Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models.Shihab HA, Gough J, Cooper DN, Stenson PD, Barker GL, Edwards KJ, Day IN, Gaunt TR.Shihab HA, et al.Hum Mutat. 2013 Jan;34(1):57-65. doi: 10.1002/humu.22225. Epub 2012 Nov 2.Hum Mutat. 2013.PMID:23033316Free PMC article.
- Machine learning classifier for identification of damaging missense mutations exclusive to human mitochondrial DNA-encoded polypeptides.Martín-Navarro A, Gaudioso-Simón A, Álvarez-Jarreta J, Montoya J, Mayordomo E, Ruiz-Pesini E.Martín-Navarro A, et al.BMC Bioinformatics. 2017 Mar 7;18(1):158. doi: 10.1186/s12859-017-1562-7.BMC Bioinformatics. 2017.PMID:28270093Free PMC article.
- Computational prediction of the effects of non-synonymous single nucleotide polymorphisms in human DNA repair genes.Nakken S, Alseth I, Rognes T.Nakken S, et al.Neuroscience. 2007 Apr 14;145(4):1273-9. doi: 10.1016/j.neuroscience.2006.09.004. Epub 2006 Oct 19.Neuroscience. 2007.PMID:17055652Review.
- Integrating Large-Scale Protein Structure Prediction into Human Genetics Research.Correa Marrero M, Jänes J, Baptista D, Beltrao P.Correa Marrero M, et al.Annu Rev Genomics Hum Genet. 2024 Aug;25(1):123-140. doi: 10.1146/annurev-genom-120622-020615. Epub 2024 Aug 6.Annu Rev Genomics Hum Genet. 2024.PMID:38621234Review.
Cited by
- Advances in predicting breast cancer driver mutations: Tools for precision oncology (Review).Hao W, Rajendran BK, Cui T, Sun J, Zhao Y, Palaniyandi T, Selvam M.Hao W, et al.Int J Mol Med. 2025 Jan;55(1):6. doi: 10.3892/ijmm.2024.5447. Epub 2024 Oct 25.Int J Mol Med. 2025.PMID:39450552Free PMC article.Review.
- Novel SERPINA1 Alleles Identified through a Large Alpha-1 Antitrypsin Deficiency Screening Program and Review of Known Variants.Wiesemann GS, Oshins RA, Flagg TO, Brantly ML.Wiesemann GS, et al.Chronic Obstr Pulm Dis. 2023 Jan 25;10(1):7-21. doi: 10.15326/jcopdf.2022.0321.Chronic Obstr Pulm Dis. 2023.PMID:36367950Free PMC article.
- IARS2 mutations lead to Leigh syndrome with a combined oxidative phosphorylation deficiency.Dong Q, Yin X, Fan S, Zhong S, Yang W, Chen K, Wang Q, Ma X, Mahlatsi RL, Yang Y, Lyu J, Fang H, Wang Y.Dong Q, et al.Orphanet J Rare Dis. 2024 Aug 21;19(1):305. doi: 10.1186/s13023-024-03310-x.Orphanet J Rare Dis. 2024.PMID:39169373Free PMC article.
- Ultra-Rare BRD9 Loss-of-Function Variants Limit the Antiviral Action of Interferon.Mair NK, Hale BG.Mair NK, et al.Sci Rep. 2022 Sep 13;12(1):15360. doi: 10.1038/s41598-022-19648-w.Sci Rep. 2022.PMID:36100643Free PMC article.
- Complex Autism Spectrum Disorder in a Patient with a Novel De Novo HeterozygousMYT1L Variant.Yip S, Calli K, Qiao Y, Trost B, Scherer SW, Lewis MES.Yip S, et al.Genes (Basel). 2023 Nov 24;14(12):2122. doi: 10.3390/genes14122122.Genes (Basel). 2023.PMID:38136944Free PMC article.
References
- Ashley EA, Butte AJ, Wheeler MT, Chen R, Klein TE, Dewey FE, Dudley JT, Ormond KE, Pavlovic A, Morgan AA, Pushkarev D, Neff NF, Hudgins L, Gong L, Hodges LM, Berlin DS, Thorn CF, Sangkuhl K, Hebert JM, Woon M, Sagreiya H, Whaley R, Knowles JW, Chou MF, Thakuria JV, Rosenbaum AM, Zaranek AW, Church GM, Greely HT, Quake SR, Altman RB. Clinical assessment incorporating a personal genome. Lancet. 2010;375:1525–1535. - PMC - PubMed
- Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, Nickerson DA, Shendure J. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet. 2011;12:745–755. - PubMed
- Chasman D, Adams RM. Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: Structure-based assessment of amino acid variation. J Mol Biol. 2001;307:683–706. - PubMed
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources